SpaceX’s inclusion in major indexes triggers billions in passive inflows, a model set to repeat for other private tech firms. SpaceX entered the CRSP US Total Market Index on June 18, five days after its IPO priced at $135 per share. The move forced passive funds like Vang
AVAV to report Q4 results with consensus EPS of $1.47 and revenue surging 103.3% year-over-year. AeroVironment (AVAV) will release its Q4 2026 earnings after the market closes on June 29. Analysts expect earnings per share of $1.47, an 8.7% decline from the same period las
Analysts project SpaceX could surpass Nvidia's $4.7 trillion market cap, with targets reaching $10 trillion within five years. SpaceX briefly became the fourth-largest company by market cap during its third trading day, now ranking in the top 10. Its rapid ascent has drawn
Coca-Cola is a top dividend stock to buy with $3,000 Coca-Cola is considered a stable company with an established economic moat. The company's operating margin in Q1 was 35%, supported by a history of pricing power due to customer loyalty. Coca-Cola's success is
Alphabet’s 15% decline from mid-May highs weighs on the S&P 500, prompting investor interest in other megacap tech stocks. Alphabet’s 15% drop from its mid-May peak has led a broader retreat in megacap technology stocks, impacting the S&P 500. The decline follows a period
CoreWeave’s valuation rises 11% since Nvidia’s $2 billion investment, fueled by AI infrastructure demand and major contracts. Nvidia’s $2 billion investment in AI infrastructure provider CoreWeave (CRWV) has appreciated 11% since January, reflecting growing demand for AI d
Auto insurer Progressive holds a $96 billion bond-heavy portfolio, generating $1.5 billion in Q1 investment income despite economic downturn concerns. Progressive (PGR) remains resilient in recession scenarios due to its $96 billion investment portfolio, over 90% of which
RBC Capital initiated GE HealthCare Technologies with an Outperform rating and an $80 price target, citing strong R&D and growth potential. RBC Capital initiated coverage of GE HealthCare Technologies Inc. (NASDAQ:GEHC) with an Outperform rating and an $80 price target. Th
Veeva Falcon MLR aims to cut over 70% of manual medical, legal, and regulatory review work within five years. Veeva Systems (VEEV) introduced Veeva Falcon MLR, an AI-driven platform for automating medical, legal, and regulatory content reviews. The tool checks materials ag
Mizuho reduced Insmed's price target amid a 29% share decline but sees the selloff as a buying opportunity for the biopharma stock. Mizuho lowered its price target for Insmed Incorporated (NASDAQ:INSM) to $192 from $202 while maintaining an Outperform rating. The firm cite
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.